Allelic loss at the short arm of chromosome 3 is one of the most common and earliest events in the pathogenesis of lung cancer, and is observed in more than 90% of small-cell lung cancers (SCLCs) and in 50–80% of non-small-cell lung cancers1,2 (NSCLCs). Frequent and early loss of heterozygosity and the presence of homozygous deletions suggested a critical role of the region 3p21.3 in tumorigenesis2,3,4 and a region of common homozygous deletion in 3p21.3 was narrowed to 120 kb (ref. 5). Several putative tumour-suppressor genes located at 3p21 have been characterized, but none of these genes appear to be altered in lung cancer. Here we describe the cloning and characterization of a human RAS effector homologue (RASSF1) located in the 120-kb region of minimal homozygous deletion. We identified three transcripts, A, B and C, derived from alternative splicing and promoter usage. The major transcripts A and C were expressed in all normal tissues. Transcript A was missing in all SCLC cell lines analysed and in several other cancer cell lines. Loss of expression was correlated with methylation of the CpG-island promoter sequence of RASSF1A. The promoter was highly methylated in 24 of 60 (40%) primary lung tumours, and 4 of 41 tumours analysed carried missense mutations. Re-expression of transcript A in lung carcinoma cells reduced colony formation, suppressed anchorage-independent growth and inhibited tumour formation in nude mice. These characteristics indicate a potential role for RASSF1A as a lung tumour suppressor gene.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Whang-Peng, J. et al. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science 215, 181–182 (1982).
Kok, K., Naylor, S.L. & Buys, C.H.C.M. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 71, 27–92 (1997).
Hung, J. et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273, 558–563 (1995).
Wistuba, I.I. et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18, 643–650 (1999).
Sekido, Y. et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 16, 3151–3157 (1998).
Wei, M.-H. et al. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res. 56, 1487–1492 (1996).
Vavvas, D., Li, X., Avruch, J. & Zhang, X.-F. Identification of Nore1 as a potential Ras effector. J. Biol. Chem. 273, 5439–5442 (1998).
Ponting, C.P. & Benjamin, D.R. A novel family of Ras-binding domains. Trends Biochem. Sci. 21, 422–425 (1996).
Newton, A.C. Seeing two domains. Curr. Biol. 5, 973–976 (1995).
Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. & Issa, J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141–196 (1998).
Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nature Genet. 21, 163–167 (1999).
Costello, J.F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet. 24, 132–138 (2000).
Eng, C., Herman, J.G. & Baylin, S.B. A bird's eye view of global methylation. Nature Genet. 24, 101–102 (2000).
Clark, S.J., Harrison, J., Paul, C.L. & Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22, 2990–2997 (1994).
Altschul, S.F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
Szabo, P.E. & Mann, J.R. Biallelic expression of imprinted genes in the mouse germ line: implications for erasure, establishment, and mechanisms of genomic imprinting. Genes Dev. 9, 1857–1868 (1995).
We thank C.A. Tessler for technical support. This work was supported by a grant from the University of California Tobacco Related Disease Research Program (6RT-0361 to G.P.P.).
About this article
Homogeneous fluorescent biosensing method for DNA methyltransferase activity analysis and inhibitor screening based on highly efficient isothermal amplification
Sensors and Actuators B: Chemical (2019)
Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21 WAF1 activation in a p53‐dependent manner
Journal of Gastroenterology and Hepatology (2019)
Precision Clinical Medicine (2019)